Latest AI and machine learning research in myeloma for healthcare professionals.
BACKGROUND AND OBJECTIVE: Relapse in Multiple Myeloma, driven by therapy-resistant cancer stem cells, necessitates the development of more specific and accurate prognostic models. Existing stemness indices often lack specificity for the unique biology of Multiple Myeloma. This study aimed to develop, validate, and optimize a novel prognostic gene signature derived from Side Population cells, a wel...
BACKGROUND: Anemia is one of the most common hematological disorders causing fatigue, increased vulnerability to infection, low birth weight, and threatening the physical and mental development of children. Hence, the early identification reduces the risk of patients and facilitates early intervention. On the other hand, the blood collection of the adults is simple, and the results will be precise...
INTRODUCTION: Thalassemia is a major global health concern, as declared by the World Health Organization (WHO). Accurate screening of heterozygotes is...
PURPOSE: To develop and validate an AI method for automated quantification of whole-skeleton bone marrow (BM) metabolic activity using Carbon 11 (11C)...
Transcranial ultrasound imaging plays an important role in the diagnosis of brain diseases and the monitoring of brain function. However, the quality ...
OBJECTIVES: Anemia is a significant global health concern, with hypochromic microcytic anemia being the most common type. Among its causes, β-thalasse...
Chronic kidney disease (CKD) is a prevalent global health issue, and nutritional management of CKD is an integral component through all stages of the ...
PURPOSE: The clinical significance of medullary abnormalities in the appendicular skeleton detected by computed tomography (CT) in patients with multi...
INTRODUCTION: Bleeding is a serious complication in cardiac surgery, especially among patients receiving combined anticoagulant and antiplatelet thera...
Glycosylation abnormalities are critical in the progression of various cancers. However, their role in the onset and prognosis of multiple myeloma (MM...
AIMS: To identify predictors for initiation of frontline doublet versus triplet therapy for transplant-ineligible newly diagnosed multiple myeloma.
BACKGROUND: Multiple myeloma (MM) is a hematological malignancy that progresses from a benign precursor stage known as Monoclonal Gammopathy of Undete...
PANoptosis is closely associated with tumorigenesis and therapeutic response, yet its role in multiple myeloma (MM) remains unclear. This study analyz...
INTRODUCTION: Thalassemia trait (TT) and iron deficiency anemia (IDA) are two common types of microcytic hypochromic anemia (MHA), but current diagnos...
Multiple myeloma evolves unnoticed over years, and when diagnosed, organ damage is common. Electronic health records (EHR) can help in developing pred...
Beta-thalassemia is a genetic disorder that significantly burdens healthcare systems globally. This inherited blood disorder, categorized into beta-th...
Differentiating between immune thrombocytopenia (ITP), aplastic anemia (AA), and myelodysplastic syndromes (MDS) is critical due to the distinct treat...
The detection and classification of blood cells are important in diagnosing and monitoring a variety of blood-related illnesses, such as anemia, leuke...
Multispecific antibodies have redefined the immunotherapeutic landscape in hematologic malignancies. Bispecific antibodies (BsAbs), which redirect cyt...